OLIVIERO JAMES F III (CEO, President and Director) sold 20.5% of their position (822.40K shares) of CHECKPOINT THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.07M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/20/2024ACC: 0001104659-24-130963
DirectorOfficer· CEO, President and Director
Since Jan 2019
-1.72M
Net shares
Net seller
$3.07M
Total sold
2
Open market trades
0B · 2S
3
Total transactions
1.72M disposed
Non-Derivative Transactions3
COMMON STOCK
Direct
Shares
−602.17K
Price / share
$3.87
Trade value
$2.33M
% of position
15.0%
12/18/2024
4.02M→3.41M
COMMON STOCK
Direct
Shares
−220.23K
Price / share
$3.38
Trade value
$744.38K
% of position
6.4%
12/19/2024
3.41M→3.19M
COMMON STOCK
Direct
Shares
−900K
Price / share
—
Trade value
—
% of position
28.2%
12/20/2024
3.19M→2.29M
Total
Net shares
−1.72M
Net value
-$3.07M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 12/18/2024 | S · Sale | −602.17K | $3.87 | $2.33M | 15.0% | 4.02M | 3.41M |
| COMMON STOCK Direct | 12/19/2024 | S · Sale | −220.23K | $3.38 | $744.38K | 6.4% | 3.41M | 3.19M |
| COMMON STOCK Direct | 12/20/2024 | G · Gift | −900K | — | — | 28.2% | 3.19M | 2.29M |
| Total | −1.72M | -$3.07M | ||||||
Derivative Transactions0
No derivative transactions reported